shared knowledge shared progress
Lhasa Limited releases new data to Aromatic Amines database usersLhasa Limited is delighted to announce the release of new data to its Vitic Aromatic Amines database users.
15 December 2022
17 May 2022
29 April 2022
The benefits of joining the Complex Nitrosamines consortiumRead what one of our Complex Nitrosamines Data Sharing Initiative members, Graham Smith, Oncology Chemical Toxicology Lead at AstraZeneca, has to say about being involved in this growing consortium!
10 October 2022
22 February 2022
05 August 2021
Lhasa Limited announce the launch of innovative solution to support ICH S1 carcinogenicity assessmentsLhasa Limited is thrilled to announce the launch of Kaptis!
"Kaptis is an important tool for the development and interpretation of Integrated Approaches to Testing and Assessment for carcinogenicity" – Carole Yauk, Professor and Canada Research Chair in Genomics and the Environment.
Read the full article for more information.
21 December 2022
One of the most influential scientific papers of 2022In November last year, we published a ground-breaking article to Chemical Research in Toxicology titled ‘What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure–Activity Relationships’.
Within the paper, we show that certain structural features, when treated independently, have a statistically significant impact on the carcinogenic potency of nitrosamines. It is with great excitement that we share this publication making it to Chemical Research in Toxicology’s top 20 most downloaded articles, as well as being the most viewed article within their November edition.
26 January 2023
January 2023eTOX
January 2023eTOX
January 2023Vitic
Lhasa Limited announce the launch of innovative solution to support ICH S1 carcinogenicity assessmentsLhasa Limited is thrilled to announce the launch of Kaptis!
"Kaptis is an important tool for the development and interpretation of Integrated Approaches to Testing and Assessment for carcinogenicity" – Carole Yauk, Professor and Canada Research Chair in Genomics and the Environment.
Read the full article for more information.
21 December 2022
15 December 2022
15 December 2022
One of the most influential scientific papers of 2022In November last year, we published a ground-breaking article to Chemical Research in Toxicology titled ‘What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure–Activity Relationships’.
Within the paper, we show that certain structural features, when treated independently, have a statistically significant impact on the carcinogenic potency of nitrosamines. It is with great excitement that we share this publication making it to Chemical Research in Toxicology’s top 20 most downloaded articles, as well as being the most viewed article within their November edition.
26 January 2023
06 January 2023
09 December 2022
The following links provide access to relevant Allen CHG publications for the last 2 years. If you would like to view older publications, or to refine your search criteria further please search the library.
| Title | Published | Type | Products |
|---|---|---|---|
| Systematic analysis of protein targets associated with adverse events of drugs from clinical trials and postmarketing reports | March 2021 |
© 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).
